Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radiotherapy Target Delineation After Induction Chemotherapy for Oropharyngeal Carcinoma
ChiCTR2000029712Phase 2Recruiting
- Sponsor
- Tumor Hospital Affiliated to Guizhou Medical University
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cisplatin in oropharyngeal cancer, sponsored by Tumor Hospital Affiliated to Guizhou Medical University. Primary endpoint: Radiotherapy target area delineation of gross tumor volume (GTV) after induction chemotherapy. Started Feb 2020; status: recruiting.
02
Drugs
cisplatin
03
Conditions
oropharyngeal cancer
Beyond the preview
Go deeper on ChiCTR2000029712.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000029712.